Logo of CARBOGEN AMCIS

CARBOGEN AMCIS

CARBOGEN AMCIS, a Dishman Carbogen Amcis Company, is a global development and manufacturing partner for complex medicines. Specialisms include high-potency APIs, linker and payload chemistry, precise bioconjugation for ADCs and clinical-to-commercial sterile fill-finish. Integrated analytics and CMC/regulatory capabilities reduce handoffs and accelerate timelines, while flow-enabled process design and engineered containment enhance control, throughput and safety at scale. Facilities across Europe and Asia support development, clinical supply and commercial manufacture.

Content by CARBOGEN AMCIS

A person in protective clothing in a biologics lab
| 2 min read
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A network of interconnected human icons overlaid on a world map, representing global collaboration and population-scale data connections.
New collaborative initiatives are bringing pharmaceutical R&D together around large-scale datasets to accelerate therapeutic discovery.
Modeling neurotropic viral infections using human cerebral organoids
Using fetal-stage brain organoids, researchers are uncovering how Zika virus impacts neurodevelopment and contributes to microcephaly. 
Completing the real-time data picture in bioprocess development
Explore approaches to integrating timely protein titer measurements with cell health data to improve bioprocess visibility and decision-making.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue